temozolomide has been researched along with Multiple Primary Neoplasms in 13 studies
Excerpt | Relevance | Reference |
---|---|---|
" We retrospectively surveyed 32 patients with GBM or GBM with oligodendroglioma component (GBMO) who underwent biopsy or maximal tumor resection followed by concurrent radiotherapy and temozolomide (TMZ)." | 7.79 | IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy. ( Houkin, K; Kamoshima, Y; Kobayashi, H; Motegi, H; Murata, J; Tanino, M; Terasaka, S; Yamaguchi, S, 2013) |
" A 67-year-old renal transplant recipient developed a nodular malignant melanoma after 30 years of immunosuppression with azathioprine and prednisolone." | 7.75 | Nodular malignant melanoma and multiple cutaneous neoplasms under immunosuppression with azathioprine. ( Guenova, E; Hoetzenecker, W; Lichte, V; Moehrle, M; Roecken, M; Schaller, M; Woelbing, F, 2009) |
"The present observation suggests that temozolomide may be an active and well tolerated treatment for malignant melanoma brain metastases." | 7.72 | Complete response of multiple melanoma brain metastases after treatment with temozolomide. ( Dvorak, J; Hadzi-Nikolov, D; Melichar, B; Petera, J; Zizka, J, 2004) |
" We retrospectively surveyed 32 patients with GBM or GBM with oligodendroglioma component (GBMO) who underwent biopsy or maximal tumor resection followed by concurrent radiotherapy and temozolomide (TMZ)." | 3.79 | IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy. ( Houkin, K; Kamoshima, Y; Kobayashi, H; Motegi, H; Murata, J; Tanino, M; Terasaka, S; Yamaguchi, S, 2013) |
" A 67-year-old renal transplant recipient developed a nodular malignant melanoma after 30 years of immunosuppression with azathioprine and prednisolone." | 3.75 | Nodular malignant melanoma and multiple cutaneous neoplasms under immunosuppression with azathioprine. ( Guenova, E; Hoetzenecker, W; Lichte, V; Moehrle, M; Roecken, M; Schaller, M; Woelbing, F, 2009) |
"The present observation suggests that temozolomide may be an active and well tolerated treatment for malignant melanoma brain metastases." | 3.72 | Complete response of multiple melanoma brain metastases after treatment with temozolomide. ( Dvorak, J; Hadzi-Nikolov, D; Melichar, B; Petera, J; Zizka, J, 2004) |
"The major difficulty in treating glioblastoma stems from the intrinsic privileged nature of the brain." | 1.56 | Vascularized Temporoparietal Fascial Flap: A Novel Surgical Technique to Bypass the Blood-Brain Barrier in Glioblastoma. ( Abrams, M; Anderson, T; Boockvar, JA; D'Amico, R; Faltings, L; Filippi, CG; Fralin, S; Khatri, D; Langer, DJ; Li, M; Patel, NV; Ratzon, F; Reichman, N; Wong, T, 2020) |
"We studied 53 MG-PNETs in patients from 12 to 80 years of age (median = 54 years)." | 1.35 | Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. ( Burger, PC; Cochran, EJ; Gujrati, M; Holland, EC; Huse, JT; Jost, SC; Miller, CR; Perry, A; Qian, J; Raghavan, R; Rosenblum, MK; Scheithauer, BW; Zambrano, SC, 2009) |
"The anterior temporal lesion was a ganglioglioma and did not recur." | 1.34 | Ganglioglioma occurring with glioblastoma multiforme: separate lesions or the same lesion? ( Dickerman, RD; Howes, G; Lee, JM; Nardone, EM; Stevens, QE, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (46.15) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Patel, NV | 1 |
Khatri, D | 1 |
D'Amico, R | 1 |
Abrams, M | 1 |
Reichman, N | 1 |
Filippi, CG | 1 |
Anderson, T | 1 |
Ratzon, F | 1 |
Wong, T | 1 |
Fralin, S | 1 |
Li, M | 1 |
Faltings, L | 1 |
Langer, DJ | 1 |
Boockvar, JA | 1 |
Dirilenoglu, F | 1 |
Yukselen, OO | 1 |
Mocan, G | 1 |
Carroll, KT | 1 |
Hirshman, B | 1 |
Ali, MA | 1 |
Alattar, AA | 1 |
Brandel, MG | 1 |
Lochte, B | 1 |
Lanman, T | 1 |
Carter, B | 1 |
Chen, CC | 1 |
Xu, DS | 1 |
Rosenfeld, A | 1 |
Ponce, FA | 1 |
Nakaji, P | 1 |
Bhardwaj, RD | 1 |
Matsumura, N | 1 |
Nakajima, N | 1 |
Yamazaki, T | 1 |
Nagano, T | 1 |
Kagoshima, K | 1 |
Nobusawa, S | 1 |
Ikota, H | 1 |
Yokoo, H | 1 |
Guenova, E | 1 |
Lichte, V | 1 |
Hoetzenecker, W | 1 |
Woelbing, F | 1 |
Moehrle, M | 1 |
Roecken, M | 1 |
Schaller, M | 1 |
Motegi, H | 1 |
Kamoshima, Y | 1 |
Terasaka, S | 1 |
Kobayashi, H | 1 |
Yamaguchi, S | 1 |
Tanino, M | 1 |
Murata, J | 1 |
Houkin, K | 1 |
Patil, CG | 1 |
Yi, A | 1 |
Elramsisy, A | 1 |
Hu, J | 1 |
Mukherjee, D | 1 |
Irvin, DK | 1 |
Yu, JS | 1 |
Bannykh, SI | 1 |
Black, KL | 1 |
Nuño, M | 1 |
Dvorak, J | 1 |
Melichar, B | 1 |
Zizka, J | 1 |
Hadzi-Nikolov, D | 1 |
Petera, J | 1 |
Stevens, QE | 1 |
Howes, G | 1 |
Dickerman, RD | 1 |
Lee, JM | 1 |
Nardone, EM | 1 |
Benveniste, RJ | 1 |
Manzano, G | 1 |
Petito, CK | 1 |
Dehart, WK | 1 |
Gilliam, AC | 1 |
Lu, KQ | 1 |
Brell, J | 1 |
Perry, A | 1 |
Miller, CR | 1 |
Gujrati, M | 1 |
Scheithauer, BW | 1 |
Zambrano, SC | 1 |
Jost, SC | 1 |
Raghavan, R | 1 |
Qian, J | 1 |
Cochran, EJ | 1 |
Huse, JT | 1 |
Holland, EC | 1 |
Burger, PC | 1 |
Rosenblum, MK | 1 |
13 other studies available for temozolomide and Multiple Primary Neoplasms
Article | Year |
---|---|
Vascularized Temporoparietal Fascial Flap: A Novel Surgical Technique to Bypass the Blood-Brain Barrier in Glioblastoma.
Topics: Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain Neoplasms; Chemoradiotherapy, Adjuvant | 2020 |
Spindle cell melanoma coexisting with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare collision tumor in multiple sites.
Topics: Aged, 80 and over; Antigens, CD20; Antineoplastic Agents, Alkylating; Biopsy; CD5 Antigens; Fatal Ou | 2020 |
Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Astrocytoma; Brain N | 2017 |
Cerebral peduncle tumor ablated by novel 3-mm laser tip.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Camptothecin; Cerebral Ped | 2015 |
Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Cranial Irradiation; Da | 2017 |
Nodular malignant melanoma and multiple cutaneous neoplasms under immunosuppression with azathioprine.
Topics: Aged; Antineoplastic Agents, Alkylating; Azathioprine; Carcinoma, Basal Cell; Carcinoma, Squamous Ce | 2009 |
IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy.
Topics: Adult; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Brain Neoplasms; Combined Modality Ther | 2013 |
Prognosis of patients with multifocal glioblastoma: a case-control study.
Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Case-Control Studies; Cohort Studies; Combined Modalit | 2012 |
Complete response of multiple melanoma brain metastases after treatment with temozolomide.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Humans; Magnetic Resonance | 2004 |
Ganglioglioma occurring with glioblastoma multiforme: separate lesions or the same lesion?
Topics: Antineoplastic Agents, Alkylating; Astrocytes; Biomarkers, Tumor; Brain Neoplasms; Chemotherapy, Adj | 2007 |
Multifocal glioblastoma multiforme with synchronous spontaneous hemorrhage: case report.
Topics: Aged; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cerebral Hemorr | 2008 |
A rare case of melanoma recurring as subcutaneous metastatic melanoma with overlying ecchymoses.
Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Biopsy; Dacarbazine; Ecchymosis; Female; Human | 2008 |
Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Comb | 2009 |